Item List

B. Riley Mind, Muscle & Vision Summit

Why capital is increasingly flowing to neuroscience companies that can show commercial differentiation potential on top of positive clinical data

Highlights Q2 2026

Agentic AI for Pharma Commercialization Go-to-Market Strategy
Medical Device Competitive Positioning & Board Advisory
AI-Enabled Cardiac Device Market Entry Strategy
Emerging Cardiovascular Device Commercial & Fundraising Assessment
Academic Medical Center Digital Health Investment Strategy
Chronic Hypoparathyroidism Patient Journey & Launch Strategy
Prostate Cancer Diagnostics US Partnering & Commercialization Strategy

Spotlight on Neuroimaging Summer 2026

Highlighting commercial opportunities across FSI's Measure–Modulate–Remodel framework